🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

About to kick off #ESMO2024 in Barcelona. Looking fwd to catching up with friends, connecting with new colleagues and establishing new #Partnerships with Cancer Core Europe Learn more about #CancerCoreEurope in our recent paper Cancer Discovery: aacrjournals.org/cancerdiscover… #CancerResearch

Beautiful example of #engagement of scientists with local communities in Rapa Nui island. “the authors went to the communities and asked [for] their consent.” 🤝 Genomic #archeology study nature sheds light on decline of indigenous populations with the arrival of Europeans.

Great turnout at the #CCE Clinical Trials & Translational Research reception in Barcelona! It was wonderful to see the working group come together to connect and network. Many thanks to all attendees ✨ #ESMO24 #ClinicalTrials #CCE_DART #BoBTrial

🩸🧬 Willing to learn more about #ctDNA development in #GIST? Please come by to this #MeetTheExpert at #ESMO24 with me and Dr. Giovanni Grignani ✍️ 🗓 Today 15/09 🕒 4-5pm 🪧 Marbella Auditorium cc5

We have an open postdoc position in my group! The projects of the lab are focused on understanding how cancer genomes dictate immune responses, tumor evolution, and therapy resistance. Come join us in a great environment! vhio.net/2024/09/18/ref…

No better lab to do your postdoc! 👇 #CancerResearch #Postdoc Postdoc Positions

A recent study suggests that reexpression of a protein found during fetal development plays a role in the suppression of immunity in early colorectal adenomas and cancers. Read the full study: nej.md/3ZzbEHH

Alarmantes datos: “seis de cada diez oncólogos europeos presentan signos de agotamiento psicológico, un 25% se plantean cambiar su carrera y más de un tercio (38%) contemplan dejar la profesión”. SEOM ESMO - Eur. Oncology abc.es/sociedad/oncol…

Amid the uncertainty, here’s what Trump’s victory might mean for U.S. science | Science | AAAS science.org/content/articl…

The immune response

Josep Ramoneda: "Elon Musk dispone de un poder que no había tenido ningún otro empresario en el capitalismo" elDiario.es Neus Tomàs Gironi eldiario.es/128_b417e6

Shifting from a profit-driven model to one that prioritizes affordability and access to advanced medicines for #patients. A timely and much needed Perspective by Melinda Kliegman and colleagues Institute for Geographic Information Science “A roadmap for affordable genetic medicines” nature.com/articles/s4158… nature

How can you increase the impact of your own research beyond the publication impact factor? 🤔 Our podcast guests @IACR_DIR, Javier Carmona 🇪🇺 & Caroline Dive (CRUK Lung Centre) discuss this in episode 7 of The Cancer Researcher Podcast: magazine.eacr.org/make-your-rese… #CancerResearch

Chimeric antigen receptor T-cell (CAR-T) therapy, already approved for certain blood cancers, is generating excitement in early tests against autoimmune diseases. Designed to wipe out a whole class of immune cells, the treatment holds promise but comes with potentially serious

Very excited to share our latest publication on the role of NOTCH1 in sexual dimorphism in liver cancer and published in Cancer Discovery! Super proud of Katherine Lindblad for leading this study as part of her outstanding PhD work.

“Immunotherapy for Early-Stage Triple-Negative Breast Cancer” is a must read editorial in ⁦⁦NEJM⁩ by my ⁦Dana-Farber⁩ ⁦Harold J. Burstein, MD, PhD, FASCO⁩. The Editorial has broad applications for testing IO in high-risk cancers in general ! Kudos Hal! nejm.org/doi/full/10.10…

✨ Gustave Roussy & Friends avec le Vall d'Hebron Institute of Oncology (#VHIO)✨ Aujourd'hui, Gustave Roussy a reçu les experts internationaux du Vall d’Hebron Institute of Oncology (VHIO), dans le cadre du Cancer Core Europe, afin de partager leurs connaissances sur des sujets clés en #cancérologie. Au programme : 🤖

📢 Dr. Direna Alonso-Curbelo receives an European Research Council (ERC) Consolidator Grant to study how #inflammation fuels tumor initiation and evolution. 💡With €2M over the next 5 years, the IGNITE Project will dive deep into #PancreaticCancer to tackle early diagnosis and the development of more

🌍 VHIO is participating in the Cancer Core Europe Annual Meeting 2025 at The Netherlands Cancer Institute. A key event to continue advancing research and innovation in oncology. #CCEAM25